TP73 is a member of the TP53 gene family and produces N- and C-terminal protein isoforms through alternative promoters, alternative translation initiation and alternative splicing. Most notably, p73 protein isoforms may either contain a p53-like transactivation domain (TAp73 isoforms) or lack this domain (ΔTAp73 isoforms) and these variants have opposing or independent functions. To date, there is a lack of well-characterised isoform-specific p73 antibodies. Here, we produced polyclonal and monoclonal antibodies to N-terminal p73 variants and the C-terminal p73α isoform, the most common variant in human tissues. These reagents show that TAp73 is a marker of multiciliated epithelial cells, while ΔTAp73 is a marker of non-proliferative basal/reserve cells in squamous epithelium. We were unable to detect ΔNp73 variant proteins, in keeping with recent data that this is a minor form in human tissues. Most cervical squamous cell carcinomas (79%) express p73α, and the distribution of staining in basal cells correlated with lower tumour grade. TAp73 was found in 17% of these tumours, with a random distribution and no association with clinicopathological features. These data indicate roles for ΔTAp73 in maintaining a non-proliferative state of undifferentiated squamous epithelial cells and for TAp73 in the production of differentiated multiciliated cells.

Department of Experimental Biology Faculty of Science Masaryk University Brno Czech Republic

Department of Pathology Masaryk Memorial Cancer Institute Brno Czech Republic

Research Center for Applied Molecular Oncology Masaryk Memorial Cancer Institute Zluty kopec 7 Brno 656 53 Czech Republic

Zobrazit více v PubMed

Lane, D. P. & Crawford, L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature278, 261–263 (1979). PubMed

Linzer, D. I., Maltzman, W. & Levine, A. J. The SV40 A gene product is required for the production of a 54,000 MW cellular tumor antigen. Virology98, 308–318 (1979). PubMed

Schmale, H. & Bamberger, C. A novel protein with strong homology to the tumor suppressor p53. Oncogene15, 1363–1367 (1997). PubMed

Kaghad, M. et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell90, 809–819 (1997). PubMed

Liu, Y., Su, Z., Tavana, O. & Gu, W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell.42, 946–967 (2024). PubMed PMC

Dickman, S. First p53 relative may be a new tumor suppressor. Science277, 1605–1606 (1997). PubMed

Jost, C. A., Marin, M. C. & Kaelin, W. G. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature389, 191–194 (1997). PubMed

Yang, A. et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature398, 714–718 (1999). PubMed

Nemajerova, A. & Moll, U. M. Tissue-specific roles of p73 in development and homeostasis. J. Cell. Sci.132, jcs233338 (2019). PubMed PMC

Inoue, K. & Fry, E. A. Alterations of p63 and p73 in human cancers. Subcell. Biochem.85, 17–40 (2014). PubMed PMC

Orzol, P. et al. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site. Histol. Histopathol. 30, 503–521 (2015). PubMed

Pokorná, Z., Vysloužil, J., Hrabal, V., Vojtěšek, B. & Coates, P. J. The foggy world(s) of p63 isoform regulation in normal cells and cancer. J. Pathol.254, 454–473 (2021). PubMed

Vikhreva, P., Melino, G. & Amelio, I. p73 alternative splicing: exploring a Biological role for the C-Terminal isoforms. J. Mol. Biol.430, 1829–1838 (2018). PubMed PMC

López, I., Valdivia, I. L., Vojtesek, B., Fåhraeus, R. & Coates, P. J. Re-appraising the evidence for the source, regulation and function of p53-family isoforms. Nucleic Acids Res.52, 12112–12129 (2024). PubMed PMC

Grob, T. J. et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell. Death Differ.8, 1213–1223 (2001). PubMed

Carithers, L. J. & Moore, H. M. The genotype-tissue expression (GTEx) project. Biopreservation Biobanking. 13, 307–308 (2015). PubMed PMC

GTEx et al. Genetic effects on gene expression across human tissues. Nature550, 204–213 (2017). PubMed PMC

Marshall, C. B. et al. Tissue-specific expression of p73 and p63 isoforms in human tissues. Cell. Death Dis.12, 745 (2021). PubMed PMC

Yang, A. et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature404, 99–103 (2000). PubMed

Maeso-Alonso, L., López-Ferreras, L. & Marques, M. M. Marin, M. C. p73 as a tissue architect. Front. Cell. Dev. Biol.9, 716957 (2021). PubMed PMC

Marshall, C. B. et al. p73 is required for Multiciliogenesis and regulates the Foxj1-Associated Gene Network. Cell. Rep.14, 2289–2300 (2016). PubMed PMC

Napoli, M. & Flores, E. R. Unifying the p73 knockout phenotypes: TAp73 orchestrates multiciliogenesis. Genes Dev.30, 1253–1254 (2016). PubMed PMC

Nemajerova, A. et al. Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism. Cell. Death Differ.25, 144–153 (2018). PubMed PMC

Nenutil, R., Ceskova, P., Coates, P. J., Nylander, K. & Vojtesek, B. Differential expression of p73alpha in normal ectocervical epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma. Int. J. Gynecol. Pathol. Off J. Int. Soc. Gynecol. Pathol.22, 386–392 (2003). PubMed

Puig, P. et al. p73 expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clin. Cancer Res. Off J. Am. Assoc. Cancer Res.9, 5642–5651 (2003). PubMed

Rosenbluth, J. M., Johnson, K., Tang, L., Triplett, T. & Pietenpol, J. A. Evaluation of p63 and p73 antibodies for cross-reactivity. Cell. Cycle Georget. Tex.8, 3702–3706 (2009). PubMed

Nekulova, M. et al. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry. Virchows Arch. Int. J. Pathol.463, 415–425 (2013). PubMed

Pellegrini, G. et al. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. U S A. 98, 3156–3161 (2001). PubMed PMC

Guo, Y., Wu, H., Wiesmüller, L. & Chen, M. Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance. Cell. Death Dis.15, 412 (2024). PubMed PMC

Logotheti, S. et al. Mechanisms of functional pleiotropy of p73 in Cancer and Beyond. Front. Cell. Dev. Biol.9, 737735 (2021). PubMed PMC

Concin, N. et al. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res.64, 2449–2460 (2004). PubMed

Dötsch, V., Bernassola, F., Coutandin, D., Candi, E. & Melino, G. p63 and p73, the ancestors of p53. Cold Spring Harb Perspect. Biol.2, a004887 (2010). PubMed PMC

Baker, M. When antibodies mislead: the quest for validation. Nature585, 313–314 (2020). PubMed

Kahn, R. A. et al. Antibody characterization is critical to enhance reproducibility in biomedical research. eLife13, e100211 (2024). PubMed PMC

Pham, T. D., Fan, C., Pfeifer, D., Zhang, H. & Sun, X. F. Image-based network analysis of DNp73 expression by immunohistochemistry in rectal Cancer patients. Front. Physiol.10, 1551 (2019). PubMed PMC

Vilgelm, A. E. et al. Characterization of ∆Np73 expression and regulation in gastric and esophageal tumors. Oncogene29, 5861–5868 (2010). PubMed PMC

Beeler, J. S. et al. p73 regulates epidermal wound healing and induced keratinocyte programming. PloS One. 14, e0218458 (2019). PubMed PMC

Marques, M. M., Villoch-Fernandez, J., Maeso-Alonso, L., Fuertes-Alvarez, S. & Marin, M. C. The Trp73 mutant mice: a Ciliopathy Model that uncouples Ciliogenesis from Planar Cell Polarity. Front. Genet.10, 154 (2019). PubMed PMC

Cochrane, D. R. et al. Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours. J. Pathol.252, 201–214 (2020). PubMed

Ishimoto, O. et al. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res.62, 636–641 (2002). PubMed

Zaika, A. I. et al. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med.196, 765–780 (2002). PubMed PMC

Di, C. et al. Mechanisms, function and clinical applications of DNp73. Cell. Cycle Georget. Tex.12, 1861–1867 (2013). PubMed PMC

Sayan, A. E. et al. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site. Ann. N Y Acad. Sci.1095, 315–324 (2007). PubMed

Li, Y. et al. p63: a crucial player in epithelial stemness regulation. Oncogene42, 3371–3384 (2023). PubMed PMC

Romano, R. A. et al. ∆Np63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Dev. Camb. Engl.139, 772–782 (2012). PubMed PMC

Strubel, A. et al. DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma. Cell. Death Dis.14, 674 (2023). PubMed PMC

Coates, P. J. et al. p63 isoforms in triple-negative breast cancer: ∆Np63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival. Virchows Arch. Int. J. Pathol.472, 351–359 (2018). PubMed

Loljung, L. et al. High expression of p63 is correlated to poor prognosis in squamous cell carcinoma of the tongue. J. Oral Pathol. Med. Off Publ Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol.43, 14–19 (2014). PubMed

Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods. 3, 995–1000 (2006). PubMed

Silverberg, S. G. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod. Pathol. Off J. U S Can. Acad. Pathol. Inc. 13, 309–327 (2000). PubMed

Richardson, M. T., Recouvreux, M. S., Karlan, B. Y., Walts, A. E. & Orsulic, S. Ciliated cells in Ovarian Cancer decrease with increasing Tumor Grade and Disease Progression. Cells11, 4009 (2022). PubMed PMC

Hibi, K. et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. U S A. 97, 5462–5467 (2000). PubMed PMC

Nylander, K. et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J. Pathol.198, 417–427 (2002). PubMed

Krejci, A., Hupp, T. R., Lexa, M., Vojtesek, B. & Muller, P. Hammock: a hidden Markov model-based peptide clustering algorithm to identify protein-interaction consensus motifs in large datasets. Bioinforma Oxf. Engl.32, 9–16 (2016). PubMed PMC